Home › Glycogen Storage Disease Type II › Virginia
Glycogen Storage Disease Type II clinical trials in Virginia
6 studies for Glycogen Storage Disease Type II are looking for participants at sites in Virginia.
Cities in Virginia
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease
- The Lysosomal & Rare Disorders Research & Treatment Center, Fairfax
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT07354724A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
- Virginia Commonwealth University (VCU), Richmond
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Jul 20, 2026 · NCT07282847Pompe Disease Registry Protocol
- O & O Alpan- Site Number : 840025, Fairfax
RecruitingObservational study
All ages · All sexes · Updated Jun 23, 2026 · NCT00231400Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
- Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), Fairfax
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT07123155Pompe Pregnancy Sub-Registry
- O & O Alpan- Site Number : 840025, Fairfax
RecruitingObservational study
All ages · Women · Updated Apr 16, 2026 · NCT00567073A Global Prospective Observational Registry of Patients With Pompe Disease
- Lysosomal and Rare Disorders Research and Treatment Center, Inc., Fairfax
RecruitingObservational study
All ages · All sexes · Updated Mar 10, 2026 · NCT06121011From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.